Compounds > 2,2-bis(4-glycidyloxyphenyl)propane
Page last updated: 2024-10-23

2,2-bis(4-glycidyloxyphenyl)propane and Hyperinsulinism

2,2-bis(4-glycidyloxyphenyl)propane has been researched along with Hyperinsulinism in 1 studies

2,2-bis(4-glycidyloxyphenyl)propane: structure

Hyperinsulinism: A syndrome with excessively high INSULIN levels in the BLOOD. It may cause HYPOGLYCEMIA. Etiology of hyperinsulinism varies, including hypersecretion of a beta cell tumor (INSULINOMA); autoantibodies against insulin (INSULIN ANTIBODIES); defective insulin receptor (INSULIN RESISTANCE); or overuse of exogenous insulin or HYPOGLYCEMIC AGENTS.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
El-Bassossy, HM1
Abo-Warda, SM1
Fahmy, A1

Other Studies

1 other study available for 2,2-bis(4-glycidyloxyphenyl)propane and Hyperinsulinism

ArticleYear
Chrysin and luteolin alleviate vascular complications associated with insulin resistance mainly through PPAR-γ activation.
    The American journal of Chinese medicine, 2014, Volume: 42, Issue:5

    Topics: Anilides; Animals; Aorta, Thoracic; Benzhydryl Compounds; Blood Glucose; Blood Pressure; Epoxy Compo

2014